Indications
Cervix, squamous cell cancer, Head and neck cancer (squamous), Hodgkin's disease, Non-Hodgkin's lymphoma, Penis-squamous cell cancer, Skin-squamous cell cancer, Testicular cancer, Vulva-squamous cell cancer, Malignant pleural effusion.

Indications
Ovarian Cancer, Brain tumours, Ewing's sarcoma, Leukemia, Lung cancer- (small cell, non small cell), Rhabdomyosarcoma, Testicular cancer

Indications
Bladder cancer (neoadjuvant, adjuvant or palliative), Ovarian cancer (first or second line), Testicular cancer (single agent or combination), Brain tumours (pediatric), Cervical cancer, Germ cell tumours, Head and neck cancer, Lung cancer, small cell; non-small cell, Neuroblastoma (pediatric), Osteosarcoma (pediatric), Esophageal cancer,Wilm’s (pediatric)

Indications
Locally advanced or metastatic breast cancer, Locally advanced or metastatic non-small cell lung cancer, Recurrent or metastatic squamous cell carcinoma of the head and neck, Metastatic carcinoma of the ovary, metastatic prostate cancer.

Indications
Acute lymphocytic leukemia, Acute myeloblastic leukemia, Bladder cancer, Breast cancer, Endometrial cancer, Gastric cancer,
Head and neck cancer, squamous cell, Hodgkin’s disease, Small cell lung cancer, Non small cell lung cancer, Neuroblastoma,
Non-Hodgkin’s lymphoma, Osteogenic sarcoma, Ovarian and gynaecologic cancer, Sarcoma, soft tissue, Testicular cancer,Thyroid cancer, Wilms’ tumour.

Indications
Breast cancer, Gastric cancer, Hodgkin’s disease, Lung cancer (small and non-small cell), Non-Hodgkin’s lymphoma, Ovarian cancer.

Indications
Lung cancer: (small cell, non-small cell), Malignant lymphoma ,Testicular cancer (germ cell and seminoma), Ovarian epithelial cancer.

Indications
To decrease incidence of febrile neutropenia and its Sequelae in patients with- non-myeloid malignancies receiving Myelosuppressive chemotherapy, following induction and consolidation treatment For acute myeloid leukaemia, myeloablative chemotherapy followed by bone Marrow transplantation (BMT). To mobilize autologous peripheral blood progenitor cells for patients undergoing peripheral blood progenitor cell (PBPC) Collection. To increase neutrophil counts and reduce the incidence and duration of infections- In patients with HIV infection, In patients with severe chronic neutropenia

Indications
Adenocarcinoma of the pancreas, non-small cell lung cancer, TCC of the bladder, breast cancer.

Indications
Cervical cancer (single agent or combination), Sarcoma, soft tissue (1st or 2nd line), Pancreatic cancer (2nd line) MESNA prevents hemorrhagic cystitis secondary to Ifosfamide

Indications
Metastatic colorectal cancer, stage III (Duke's C) colon cancer after complete resection of primary tumor, metastatic colorectal cancer, stage II or III rectal cancer.

Indications
Breast cancer, Non-small cell lung cancer, Ovarian cancer, Aids related Kaposi’s sarcoma

Indications
Acute lymphocytic leukemia , Breast cancer ,Osteo and Soft Tissue Sarcoma, Hodgkin's disease, Lung cancer, small cell, Non-Hodgkin's lymphoma, Wilm's, neuroblastoma, rhabdomyosarcoma , Ovarian and cervical Cancer, Colorectal cancer, Melanoma.

Indications
Treatment of tumour-induced hypercalcemia, Treatment of patients with documented bone metastases from solid tumours and patients with osteolytic lesions of multiple myeloma, treatment of osteoporosis in postmenopausal women.